CCEL
CRYO CELL INTERNATIONAL INC
-0.03 (-0.68%)4.38USD1.6K成交股數35.3M市值–本益比(近四季)1.1股價營收比-1.9%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 11 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 7.8M-2% | 7.7M-4% | 7.8M-3% | 7.8M-3% | 7.9M+1% | 8.0M+1% | 8.1M+3% | 8.0M+3% | 7.9M | 7.9M | 7.9M | 7.8M |
| 營業成本 | 1.7M | 1.7M | 1.7M | 1.8M | 1.9M | 2.0M | 2.1M | 2.0M | 2.1M | 2.0M | 2.2M | 2.1M |
| 毛利 | 6.1M+0% | 6.0M+1% | 6.1M+3% | 6.0M+0% | 6.1M+5% | 6.0M+2% | 5.9M+4% | 6.0M+7% | 5.8M | 5.9M | 5.7M | 5.6M |
| 毛利率 | 78.4% | 78.4% | 77.9% | 77.0% | 76.6% | 75.1% | 73.6% | 74.8% | 73.7% | 74.3% | 72.6% | 72.4% |
| 研發費用 | 100K | 66K | 85K | 62K | 132K | 98K | 194K | 241K | 503K | 444K | 344K | 305K |
| 銷售管理費用 | 4.6M | 5.0M | 5.4M | 3.9M | 4.3M | 4.6M | 4.2M | 4.0M | 4.4M | 5.4M | 3.8M | 4.0M |
| 營業利益 | 1.2M-20% | 765K-28% | −4.0M-385% | 1.9M+37% | 1.5M+82% | 1.1M-107% | 1.4M+20% | 1.4M+35% | 821K | −16.2M | 1.2M | 1.0M |
| 營業利益率 | 15.4% | 10.0% | -50.6% | 24.3% | 18.8% | 13.3% | 17.2% | 17.3% | 10.5% | -205.4% | 14.8% | 13.2% |
| 稅後淨利 | 555K+56% | 47K-83% | −3.8M-463% | 749K+14% | 356K-36% | 283K-103% | 1.1M+55% | 656K+197% | 556K | −11.2M | 681K | 221K |
| 淨利率 | 7.1% | 0.6% | -48.7% | 9.6% | 4.5% | 3.5% | 13.0% | 8.2% | 7.1% | -142.1% | 8.6% | 2.8% |
| 稀釋 EPS | 0.07+75% | 0.01-67% | -0.46-454% | 0.09+13% | 0.04-43% | 0.03-102% | 0.13+63% | 0.08+167% | 0.07 | -1.34 | 0.08 | 0.03 |
| 稀釋股數 | 8.1M | 8.1M | 8.1M | 8.1M | 8.1M | 8.2M | 8.2M | 8.2M | 8.3M | 8.3M | 8.3M | 8.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 507K | 250K | 319K | 265K | 137K | 223K | 197K | 469K | 247K | 406K | 584K | 1.1M |
| 應收帳款 | 6.9M | 6.8M | 6.8M | 6.8M | 6.9M | 7.2M | 6.9M | 6.8M | 6.7M | 6.6M | 6.4M | 6.7M |
| 存貨 | 310K | 357K | 409K | 655K | 677K | 730K | 731K | 708K | 755K | 769K | 1.1M | 879K |
| 總資產 | 60.7M | 60.9M | 61.7M | 63.2M | 64.4M | 64.4M | 62.9M | 62.6M | 61.7M | 64.7M | 69.8M | 68.8M |
| 有息負債 | 8.3M | 8.3M | 8.4M | 8.4M | 8.4M | 8.5M | 8.5M | 8.5M | 8.6M | 8.6M | 8.6M | 8.7M |
| 總負債 | 78.5M | 79.3M | 80.3M | 78.0M | 80.0M | 79.0M | 72.5M | 73.3M | 72.0M | 72.3M | 69.8M | 69.6M |
| 股東權益 | −17.8M | −18.4M | −18.6M | −14.8M | −15.6M | −14.7M | −9.6M | −10.7M | −10.3M | −11.0M | −16K | −858K |
| 負債比 | 129.3% | 130.2% | 130.1% | 123.5% | 124.1% | 122.8% | 115.2% | 117.2% | 116.8% | 111.7% | 100.0% | 101.2% |
| 淨現金(現金 − 有息負債) | −7.8M | −8.1M | −8.0M | −8.1M | −8.3M | −8.2M | −8.3M | −8.1M | −8.3M | −8.2M | −8.0M | −7.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 652K-32% | – | – | – | 954K | – | – | −357K | – | – | – |
| 資本支出 | – | 67K | – | – | – | 62K | – | – | 458K | – | – | – |
| 自由現金流 | – | 585K-34% | – | – | – | 892K | – | – | −815K | – | – | – |
| 折舊攤銷 | 184K | 244K | 361K | 186K | 190K | 248K | 195K | 60K | 86K | 467K | 281K | 281K |
| 買回庫藏股 | – | – | – | – | – | 0 | – | – | 170K | – | – | – |
| 現金股利 | – | 0 | – | – | – | 2.0M | – | – | 0 | – | – | – |
| 自由現金流率 | – | 7.6% | – | – | – | 11.2% | – | – | -10.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 31.6M
| Umbilical Cord Blood And Cord Tissue Stem Cell Service | 31.4M | 99.4% | -0.5% |
|---|---|---|---|
| Public Cord Blood Banking | 130K | 0.4% | -64.7% |
| Prepacytecb | 54K | 0.2% | -20.3% |
產品／服務2025 年度 · 31.6M
| Processing And Storage Fees | 31.4M | 99.4% | -0.5% |
|---|---|---|---|
| Public Banking | 130K | 0.4% | -64.7% |
| 產品 | 54K | 0.2% | -20.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 31.6M | -1.3% | −2.4M | -7.7% | -0.30 | 5.2M |
| FY2024 | 32.0M | +2.0% | 402K | 1.3% | 0.05 | 3.6M |
| FY2023 | 31.3M | +3.3% | −9.5M | -30.4% | -1.14 | 2.1M |
| FY2022 | 30.3M | +5.0% | 2.8M | 9.1% | 0.33 | −3.6M |
| FY2021 | 28.9M | -7.3% | 2.1M | 7.2% | 0.25 | 6.1M |
| FY2020 | 31.1M | -2.1% | 3.6M | 11.6% | 0.45 | 8.4M |
| FY2019 | 31.8M | +8.9% | 2.3M | 7.2% | 0.27 | 5.6M |
| FY2018 | 29.2M | – | −855K | -2.9% | -0.11 | 4.9M |